Shengdong Wang

1.8k total citations · 1 hit paper
48 papers, 1.3k citations indexed

About

Shengdong Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shengdong Wang has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Immunology. Recurrent topics in Shengdong Wang's work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (5 papers). Shengdong Wang is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (5 papers). Shengdong Wang collaborates with scholars based in China, Japan and United States. Shengdong Wang's co-authors include Zhaoming Ye, Jie Bai, Binghao Li, Hengyuan Li, Zhan Wang, Fucheng Luo, Erman Chen, Deting Xue, Zhijun Pan and Tao� Lv and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and ACS Nano.

In The Last Decade

Shengdong Wang

45 papers receiving 1.3k citations

Hit Papers

Multi-Component Synthesis of a Buta-1,3-diene-Linked Cova... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengdong Wang China 23 464 226 222 209 150 48 1.3k
Xiaoyan Wang China 21 595 1.3× 118 0.5× 174 0.8× 68 0.3× 167 1.1× 57 1.5k
Xin Qi China 20 543 1.2× 101 0.4× 339 1.5× 123 0.6× 188 1.3× 77 1.8k
Heng Tang China 16 466 1.0× 108 0.5× 136 0.6× 87 0.4× 79 0.5× 32 899
Zijing Zhang China 24 600 1.3× 156 0.7× 176 0.8× 124 0.6× 230 1.5× 123 2.0k
Huaqing Chen China 20 637 1.4× 254 1.1× 175 0.8× 163 0.8× 473 3.2× 51 1.5k
Pingping Chen China 20 564 1.2× 278 1.2× 84 0.4× 190 0.9× 61 0.4× 61 1.4k
Xianming Wang China 21 553 1.2× 176 0.8× 512 2.3× 62 0.3× 123 0.8× 77 1.7k
Xiaoshu Zhou China 22 542 1.2× 195 0.9× 165 0.7× 122 0.6× 183 1.2× 56 1.4k
Yanlin Chen China 25 971 2.1× 214 0.9× 107 0.5× 195 0.9× 170 1.1× 80 2.0k

Countries citing papers authored by Shengdong Wang

Since Specialization
Citations

This map shows the geographic impact of Shengdong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengdong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengdong Wang more than expected).

Fields of papers citing papers by Shengdong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengdong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengdong Wang. The network helps show where Shengdong Wang may publish in the future.

Co-authorship network of co-authors of Shengdong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengdong Wang. A scholar is included among the top collaborators of Shengdong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengdong Wang. Shengdong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yinwang, Eloy, Xupeng Chai, Fangqian Wang, et al.. (2025). Musculoskeletal Diseases: Mechanisms and Therapeutic Advances. MedComm. 6(12). e70519–e70519.
3.
Chen, Shaohong, Xinghai Zhang, Yanfeng Yao, et al.. (2024). Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. Virologica Sinica. 39(6). 909–916. 5 indexed citations
4.
Zhou, Hao, Wenkan Zhang, Hengyuan Li, et al.. (2024). Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity. Science Advances. 10(3). eadi4298–eadi4298. 20 indexed citations
5.
Wang, Shengdong, Zehao Chen, Keyi Wang, et al.. (2024). Effect of radiotherapy on local control and overall survival in spinal metastasis of non-small-cell lung cancer after surgery and systemic therapy. Bone & Joint Open. 5(4). 350–360. 1 indexed citations
6.
Yinwang, Eloy, Shengdong Wang, Zenan Wang, et al.. (2024). Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes. Molecular Cancer. 23(1). 193–193. 9 indexed citations
7.
Dong, Jiabao, Xupeng Chai, Zhuo Chen, et al.. (2024). ZIF‐8‐Encapsulated Pexidartinib Delivery via Targeted Peptide‐Modified M1 Macrophages Attenuates MDSC‐Mediated Immunosuppression in Osteosarcoma. Small. 20(29). e2309038–e2309038. 9 indexed citations
8.
Zhang, Wenkan, Hao Zhou, Hengyuan Li, et al.. (2023). Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondria. Cell Reports. 42(9). 113147–113147. 31 indexed citations
9.
Mou, Haochen, Hao Qu, Binghao Li, et al.. (2022). Can “domino” therapy effectively treat the infection around the prosthesis after the limb salvage surgery of bone tumor? - A study of sequential therapy. International Journal of Surgery. 101. 106630–106630. 1 indexed citations
10.
Li, Binghao, Shan Li, Wenlong Lin, et al.. (2022). Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nature Communications. 13(1). 6308–6308. 69 indexed citations
11.
Xue, Hongyan, Tao Meng, Fangfang Liu, et al.. (2019). Enhanced resistance to calcium poisoning on Zr-modified Cu/ZSM-5 catalysts for the selective catalytic reduction of NO with NH3. RSC Advances. 9(66). 38477–38485. 27 indexed citations
12.
Wang, Zenan, Zhan Wang, Binghao Li, et al.. (2019). Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma. Frontiers in Immunology. 10. 1114–1114. 55 indexed citations
13.
Wang, Shengdong, et al.. (2019). IS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) VAL66MET POLYMORPHISM ASSOCIATED WITH OBSESSIVE-COMPULSIVE DISORDER? A META-ANALYSIS. Psychiatria Danubina. 31(2). 141–147. 9 indexed citations
14.
Wang, Zhan, Zenan Wang, Shu Li, et al.. (2018). Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis. Frontiers in Immunology. 9. 1239–1239. 33 indexed citations
15.
Nie, Jingyi, Zhengke Wang, Yi Zhou, et al.. (2016). High strength chitosan rod reinforced by non-covalent functionalized multiwalled carbon nanotubes via an in situ precipitation method. RSC Advances. 6(113). 112634–112640. 2 indexed citations
16.
Wang, Shengdong, Hengyuan Li, Binghao Li, et al.. (2016). The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma. International Immunopharmacology. 38. 81–89. 49 indexed citations
17.
Zeng, Xiansi, Jing Jia, Yong-Won Kwon, Shengdong Wang, & Jie Bai. (2013). The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease. Free Radical Biology and Medicine. 67. 10–18. 86 indexed citations
18.
Luo, Fucheng, Jia Zhou, Tao� Lv, et al.. (2012). Induction of endoplasmic reticulum stress and the modulation of thioredoxin-1 in formaldehyde-induced neurotoxicity. NeuroToxicology. 33(3). 290–298. 32 indexed citations
19.
Luo, Fucheng, Yuemei Feng, Lu Zhao, et al.. (2012). Thioredoxin-1 expression regulated by morphine in SH-SY5Y cells. Neuroscience Letters. 523(1). 50–55. 12 indexed citations
20.
Luo, Fucheng, Shengdong Wang, Lei Qi, et al.. (2010). Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. Journal of Ethnopharmacology. 133(2). 448–453. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026